Arafarma Group, S.A.: Clinical Trials

7 trials sponsored by Arafarma Group, S.A., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 recruiting. 4 Not applicable, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 3, Recruiting 1
Phase 31Completed 1
Phase 41Completed 1

Follow Arafarma Group, S.A.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Food Supplementation on Quality of Life in Patients With Endometriosis and Pelvic Pain.
Food supplement (T1675), Placebo - Endometriosis (Diagnosis)
Not applicableRecruitingArafarma Group, S.A.602026-02-262026-03-02
Impact of a Food Supplement on Musculoskeletal Pain in Women With Breast Cancer Treated With Aromatase Inhibitors.
Food supplement - Breast Cancer
Not applicableCompletedArafarma Group, S.A.302024-03-142025-10-03
Study of the Symptomatic Improvement in Patients With Fibromyalgia by Means of a Food Supplement
Food supplement - Fibromyalgia
CompletedArafarma Group, S.A.302022-03-092023-02-10
Study of the Administration of a Food Supplement in Patients With Lithiasis Treated With Extracorporeal Shock Wave Lithotripsy.
Food supplement, Placebo - Lithiasis, Nephrolithiasis
Not applicableCompletedArafarma Group, S.A.812020-04-222023-02-23
Effects of a Food Supplement on Quality of Life in Patients With Chronic Obstructive Pulmonary Disease.
Food supplement, Placebo - Chronic Obstructive Pulmonary Disease
Not applicableCompletedArafarma Group, S.A.182020-01-142022-11-15
Effects of a Food Supplement in the Prevention of Urinary Tract Infections in Kidney Transplant Patients.
MANOSARĀ®, Proanthocyanidins - Kidney Transplant Infection
Phase 4CompletedArafarma Group, S.A.602019-04-162023-03-24
Study With Two Capsaicin Topic Treatments in Diabetic Neuropathy.
Capsaicin - Diabetic Neuropathy, Painful
Phase 3CompletedArafarma Group, S.A.1612010-11-042021-09-14

Conditions studied

Breast Neoplasms (1)  ·  Diabetic Neuropathies (1)  ·  Disease (1)  ·  Endometriosis (1)  ·  Fibromyalgia (1)  ·  Lithiasis (1)  ·  Nephrolithiasis (1)  ·  Pain (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Interventions

Dietary Supplements (6)  ·  Capsaicin (1)  ·  Proanthocyanidins (1)

Countries

Spain (6)

Top investigators

Dr. Raffaelle Carraro (1)  ·  Edoardo Melilli, Doctor (1)